Home > E. Pathology by systems > Digestive system > Liver and pancreatobiliary system > Liver > non-alcoholic steatohepatitis
non-alcoholic steatohepatitis
Thursday 15 September 2011
nonalcoholic steatohepatitis, NASH
Synopsis
1. heptocytic steatosis
· >5% (beyond physiologic level)
2. steatohepatitis
· ballooned hepatocytes
· Mallory-Denk bodies
· damaged IF within hepatocytes; CAM5.2+
· portal neutrophilic infiltrate
3. steatofibrosis
· acinar zone 3 fibrosis (perivenular fibrosis/pericellular fibrosis) may progress to central-portal bridging cirrhosis
Etiology
obesity
diabetes mellitus
metabolic syndrome X
jejunoileal bypass
intestinal resection
total parenteral nutrition (TPN)
lipodystrophy
small bowel diverticulosis
metabolic diseases
hyperlipidemia
gastrointestinal surgery for obesity (by-pass surgery)
drugs
- glucocorticoids
- perhexilene maleate (Pexid)
- 4’4’-diethylaminoethoxyhexoestrol
- amiodarone
- tamoxifen
- nifedipine (Adalate)
chemicals
- petrochemicals
Differential diagnosis
Centrizonal arteries can cause central zones to be mistaken for portal tracts, especially in the setting of centrizonal ductular reaction, and result in either missed diagnosis or inaccurate staging of NASH.
The presence of centrizonal arteries must be recognized to allow for correct orientation to liver architecture in NASH and, together with the finding of increased CD34-positive microvessel formation in higher-stage fibrosis, suggests a possible association between neoangiogenesis and NASH progression to cirrhosis.
Types
TPN-induced steatohepatitis
glycogenoses (glycogen storage diseases, GSDs)
See also
steatohepatitis
- alcoholic steatohepatitis
non-alcoholic fatty liver disease (NAFLD)
References
Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med. 2008 Feb;14(2):72-81. PMID: 18218340
Videla LA, Rodrigo R, Araya J, Poniachik J. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Trends Mol Med. 2006 Dec;12(12):555-8. PMID: 17049925
Zafrani ES. Non-alcoholic fatty liver disease: an emerging pathological spectrum. Virchows Arch. 2004 Jan;444(1):3-12. PMID: 14685853
Centrizonal arteries and microvessels in nonalcoholic steatohepatitis. Gill RM, Belt P, Wilson L, Bass NM, Ferrell LD. Am J Surg Pathol. 2011 Sep;35(9):1400-4. PMID: 21836480